CL2022001481A1 - Composiciones de ácidos nucleicos - Google Patents
Composiciones de ácidos nucleicosInfo
- Publication number
- CL2022001481A1 CL2022001481A1 CL2022001481A CL2022001481A CL2022001481A1 CL 2022001481 A1 CL2022001481 A1 CL 2022001481A1 CL 2022001481 A CL2022001481 A CL 2022001481A CL 2022001481 A CL2022001481 A CL 2022001481A CL 2022001481 A1 CL2022001481 A1 CL 2022001481A1
- Authority
- CL
- Chile
- Prior art keywords
- nucleic acid
- acid compositions
- aspects
- effective
- cost
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 229920002477 rna polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
- C12N2330/51—Specially adapted vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/34—Vector systems having a special element relevant for transcription being a transcription initiation element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944824P | 2019-12-06 | 2019-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2022001481A1 true CL2022001481A1 (es) | 2023-03-17 |
Family
ID=74046190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022001481A CL2022001481A1 (es) | 2019-12-06 | 2022-06-03 | Composiciones de ácidos nucleicos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220411792A1 (https=) |
| EP (1) | EP4069843A1 (https=) |
| JP (1) | JP2023505188A (https=) |
| KR (1) | KR20220113437A (https=) |
| CN (1) | CN115397982A (https=) |
| AU (1) | AU2020395244A1 (https=) |
| CA (1) | CA3163345A1 (https=) |
| CL (1) | CL2022001481A1 (https=) |
| MX (1) | MX2022006748A (https=) |
| WO (1) | WO2021113774A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12077763B2 (en) | 2021-03-08 | 2024-09-03 | Greenlight Biosciences, Inc. | RNA-based control of powdery mildew |
| MX2023012833A (es) * | 2021-04-30 | 2024-01-23 | Greenlight Biosciences Inc | Opciones terapéuticas y composiciones de arn mensajero. |
| TW202306573A (zh) * | 2021-05-26 | 2023-02-16 | 比利時商ｅＴｈｅＲＮＡ免疫治療公司 | 減少雙股ｒｎａ副產物形成的方法 |
| CN121889507A (zh) * | 2023-08-29 | 2026-04-17 | 南京金斯瑞生物科技有限公司 | 用于非b型dna序列的克隆/表达载体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2822164B1 (fr) * | 2001-03-19 | 2004-06-18 | Centre Nat Rech Scient | Polypeptides derives des arn polymerases, et leurs utilisations |
| WO2005040388A2 (en) * | 2003-08-22 | 2005-05-06 | Nucleonics Inc. | Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments |
| RU2420584C1 (ru) * | 2009-10-29 | 2011-06-10 | Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) | Лентивирусная репортерная векторная система для измерения активности ключевых транскрипционных факторов, отражающих функциональное состояние сигнальных путей клетки |
| US9254311B2 (en) * | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| BR112020007068A2 (pt) | 2017-10-11 | 2020-10-06 | Greenlight Biosciences, Inc. | métodos e composições para produção de nucleosídeo trifosfato e ácido ribonucleico |
| AU2020253354A1 (en) * | 2019-03-29 | 2021-10-28 | Greenlight Biosciences, Inc. | Cell-free production of ribonucleic acid |
-
2020
- 2020-12-04 KR KR1020227022670A patent/KR20220113437A/ko active Pending
- 2020-12-04 US US17/779,257 patent/US20220411792A1/en active Pending
- 2020-12-04 JP JP2022533341A patent/JP2023505188A/ja active Pending
- 2020-12-04 WO PCT/US2020/063490 patent/WO2021113774A1/en not_active Ceased
- 2020-12-04 AU AU2020395244A patent/AU2020395244A1/en active Pending
- 2020-12-04 CN CN202080090794.9A patent/CN115397982A/zh active Pending
- 2020-12-04 MX MX2022006748A patent/MX2022006748A/es unknown
- 2020-12-04 EP EP20829467.8A patent/EP4069843A1/en active Pending
- 2020-12-04 CA CA3163345A patent/CA3163345A1/en active Pending
-
2022
- 2022-06-03 CL CL2022001481A patent/CL2022001481A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4069843A1 (en) | 2022-10-12 |
| CA3163345A1 (en) | 2021-06-10 |
| MX2022006748A (es) | 2023-01-19 |
| WO2021113774A1 (en) | 2021-06-10 |
| AU2020395244A1 (en) | 2022-06-16 |
| US20220411792A1 (en) | 2022-12-29 |
| KR20220113437A (ko) | 2022-08-12 |
| JP2023505188A (ja) | 2023-02-08 |
| CN115397982A (zh) | 2022-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022001481A1 (es) | Composiciones de ácidos nucleicos | |
| BR122021025194A8 (pt) | Molécula de ácido nucleico, método para obter rna, rna, método para obter um peptídeo ou proteína e usos in vitro ou ex vivo do rna | |
| CL2023002870A1 (es) | Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso | |
| MX2021010075A (es) | Variantes de arn polimerasa para la formacion de casquetes cotranscripcionales. | |
| MX2025007610A (es) | Composiciones de arni de 17beta-hidroxiesteroide deshidrogenasa tipo 13 (hsd17b13) y metodos de uso de las mismas | |
| CL2021000028A1 (es) | Anticuerpo multiespecifico (divisional de solicitud 937-2020). | |
| MX2017016688A (es) | Nuevas enzimas y sistemas crispr. | |
| EP4588512A3 (en) | Methods and compositions for treating a bleeding event in a subject having hemophilia | |
| MX2020003841A (es) | Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos. | |
| BR112018076190A2 (pt) | ortólogos e sistemas crispr tipo vi | |
| CR20190294A (es) | COMPOSICIONES DE ARNi DE SERPINA1 Y SUS MÉTODOS DE USO | |
| BR112018077188A2 (pt) | frutose-6-fosfato-3-epimerase termoestável inovadora e um método para produzir alulose com o uso da mesma | |
| MX2016016905A (es) | Ensamblaje de adn mediado por nucleasa. | |
| CL2021002262A1 (es) | Composiciones y métodos para tratar laminopatías | |
| BR112016026950A2 (pt) | composições de rnai para angiotensinogênio (agt) e métodos de uso das mesmas | |
| CR20140538A (es) | Métodos y composiciones para la modificación de adn objetivo dirigida por arn y para la modificación de la transcripción dirigida por arn | |
| MX2019006475A (es) | Sistemas y métodos para dirección con arn guía puntual (arngp) de adn endógeno y fuente. | |
| WO2018146557A3 (en) | Long double-stranded rna for rna interference | |
| AR100946A1 (es) | Composiciones y métodos para regular la expresión génica por medio de la interferencia de arn | |
| MX386450B (es) | Microorganismo recombinante para la producción mejorada de productos químicos finos. | |
| MX389370B (es) | Microorganismo recombinante para la produccion mejorada de quimicos finos. | |
| BR112022012731A2 (pt) | Anticorpo anti-ox40 e uso do mesmo | |
| BR112016015218A2 (pt) | microrganismo com capacidade melhorada de produção de l-treonina e método para produzir l-treonina com o uso desse | |
| CL2025000194A1 (es) | Construcciones de arni para inhibir expresión de scap y sus usos | |
| WO2023086938A3 (en) | Type v nucleases |